Fluvoxamine Maleate Patent Expiration

Fluvoxamine Maleate is Used for treating obsessive-compulsive disorder with an SSRI. It was first introduced by Solvay Pharmaceuticals in its drug Luvox on Dec 5, 1994. Another drug containing Fluvoxamine Maleate is Luvox Cr. 19 different companies have introduced drugs containing Fluvoxamine Maleate.


Fluvoxamine Maleate Patents

Given below is the list of patents protecting Fluvoxamine Maleate, along with the drug name that holds that patent and the company name owning that drug.

Drug Used in Drug Patent Number Drug Patent Title Drug Patent Expiry Drug Owner
Luvox Cr US7465462 Multiparticulate controlled release selective serotonin reuptake inhibitor formulations May 10, 2020

(Expired)

Jazz Pharms



Fluvoxamine Maleate's Family Patents

Family Patents

Explore Our Curated Drug Screens

Drugs Generating Over $1 Billion in Annual Revenue
Explore the top-performing drugs that dominate the pharmaceutical industry
View List
NCE-1 Patent Expiry in the Next 1 Year
Identify opportunities as new chemical entity (NCE-1) patents approach expiry
View List
Recently Granted Patents in EP
Find the opportunity to file Oppositions
View List

Fluvoxamine Maleate Generic API Manufacturers

Several generic applications have been filed for Fluvoxamine Maleate. The first generic version for Fluvoxamine Maleate was by Norvium Bioscience Llc and was approved on Nov 29, 2000. And the latest generic version is by Annora Pharma Private Ltd and was approved on Jul 30, 2025.

Given below is the list of companies who have filed for Fluvoxamine Maleate generic, along with the locations of their manufacturing plants worldwide.